Target ID:Tar87
ID:Q9HBE4
Target Name:Interleukin-21 (IL-21) (Za11)
Target Type:Protein
CID:--
URL:https://www.uniprot.org/uniprotkb/Q9HBE4
Related Drugs:--

Knowledge Graph

Drug IDDrug NameTypeDrugBank IDTargetsCategoryLatest Progress
No data available

IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in …

PMID: 31356165
Year: 2019
Relationship Type: Mechanism Investigation Score: 5.8

Group 3 innate lymphoid cells (ILC3s) have dual roles in intestinal health, acting in both protective and pathogenic capacities, and importantly, mod…

IL-21 receptor expression in human tendinopathy

PMID: 24757284
Year: 2014
Relationship Type: Mechanism Investigation Score: 5.8

The pathogenetic mechanisms underlying tendinopathy remain unclear, with much debate as to whether inflammation or degradation has the prominent role…

The role of IL-19, IL-24, IL-21 and IL-33 in intestinal mucosa of inflammatory …

PMID: 38395629
Year: 2025
Relationship Type: Therapeutic Applications Score: 5.3

Interleukins are potential therapeutic targets that can alter the prognosis and progression of inflammatory bowel disease (IBD). The roles of IL-6, I…

Kuijieling decoction regulates the Treg/Th17 cell balance in ulcerative colitis…

PMID: 37451490
Year: 2024
Relationship Type: Mechanism Investigation Score: 5.3

ETHNOPHARMACOLOGICAL RELEVANCE: Ulcerative colitis (UC) is an idiopathic intestinal disease characterized by chronic inflammation with unknown etiolo…

Expression of IL-21 and IL-33 in Intestinal Mucosa of Inflammatory Bowel Diseas…

PMID: 37443579
Year: 2023
Relationship Type: Therapeutic Applications Score: 5.3

Interleukins are considered to be potential therapeutic targets that can alter the prognosis and disease progression of IBD. IL-21 has proven to be i…

Elevated levels of IL-2 and IL-21 produced by CD4+ T cells in inflammatory bowe…

PMID: 28685527
Year: 2017
Relationship Type: Therapeutic Applications Score: 5.3

CD4+ T cells are considered as a subset of cells that play a pivotal role in the development of inflammatory bowel disease (IBD). The aim of this stu…

Human IL-21 and IL-21R deficiencies: two novel entities of primary immunodefici…

PMID: 25321844
Year: 2014
Relationship Type: Target Validation Score: 5.3

PURPOSE OF REVIEW: This review highlights the recent identification of human interleukin-21 (IL-21) and interleukin-21 receptor (IL-21R) deficiencies…

IL-21 as a therapeutic target in inflammatory disorders

PMID: 25162763
Year: 2014
Relationship Type: Therapeutic Applications Score: 5.3

INTRODUCTION: IL-21, a cytokine produced by activated CD4(+) cells, activated natural killer T cells and T helper cells in the germinal centers, is i…

Candidate IDSource IDSource TypeCompound TypeCandidate NameInclusion Criteria
No data available

Compound IDSource IDSource TypeCompound NameMolecular WeightMolecular FormulaMolecular Species
bio139751 CHEMBL1200968 Small molecule HYDROCORTISONE SODIUM PHOSPHATE 486.41 C21H29Na2O8P ACID Details
bio139752 CHEMBL2105897 Small molecule BARIUM SULFATE 233.39 BaO4S -- Details
bio139753 CHEMBL1200975 Small molecule CLOCORTOLONE PIVALATE 495.03 C27H36ClFO5 NEUTRAL Details
bio139754 CHEMBL4650250 Protein EFMARODOCOKIN ALFA -- -- -- Details
bio139755 CHEMBL2108469 Protein MUPLESTIM -- -- -- Details
bio139756 CHEMBL2109037 Protein ILODECAKIN -- -- -- Details
bio139757 CHEMBL5095282 Protein NEMVALEUKIN ALFA -- -- -- Details
bio139758 CHEMBL2107112 Small molecule TIXOCORTOL PIVALATE 462.65 C26H38O5S NEUTRAL Details
bio139759 CHEMBL1200762 Small molecule BETAMETHASONE SODIUM PHOSPHATE 516.41 C22H28FNa2O8P ACID Details
bio139760 CHEMBL5095458 Protein REZPEGALDESLEUKIN -- -- -- Details

Strategy IDTherapy StrategySynonymsRelated DrugsMechanism
No data available